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Introduction: Spinal V3 interneurons (INs) are a commissural, glutamatergic, propriospinal neuron population that
holds great potential for understanding locomotion circuitry and local rewiring after spinal cord injury. Embryonic
stem cells hold promise as a cell source. However, the inevitable heterogeneity resulting from differentiation
protocols makes studying post-mitotic stem cell-derived neuron populations difficult because proliferative glia
quickly overtake a culture. Previously, an induction protocol for V3 INs was established. However, because of the
heterogeneous population resulting from the induction protocol, functional characterization of the induced cells
was not possible.
Methods: A selectable murine transgenic embryonic stem cell (ESC) line (Sim1-Puro) was generated by
recombineering. The expression of the puromycin resistance enzyme, puromycin N-acetyl-transferase (PAC),
was knocked into the locus of a post-mitotic V3 IN marker (Sim1), allowing Sim1 gene regulatory elements to
control PAC expression. The resulting cell line was characterized for Sim1 expression by in situ hybridization, for
glutamatergic marker expression by immunocytochemistry and quantitative real time polymerase chain reaction
(qRT-PCR), and for functional maturation by electrophysiology.
Results: Puromycin selection significantly enriched the population for V3 INs, allowing long-term characterization.
The selected population expressed the neuronal marker β-III tubulin and the glutamatergic neuron marker
VGluT2. The selected V3 INs also exhibited appropriate functional maturation, as assessed by electrophysiology,
and remained glutamatergic for 2 weeks.
Conclusion: The Sim1-Puro cell line provides a simple, high throughput method for generating large numbers of
V3 INs from mouse ESCs for future in vitro and cell transplantation studies.
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Spinal interneuronIntroduction
Pluripotent stem cells have the potential to be a plentiful
cell source for many different cell types. Differentiation
protocols have been established to generate specific cell
types from embryonic stem cells (ESCs) and induced
pluripotent stem cells. In the central nervous system, dif-
ferentiation protocols for ESCs have been developed for
several populations, including midbrain and hindbrain* Correspondence: sakiyama@wustl.edu
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motoneurons (MNs) [3, 4], and V0, V2a, and V3 spinal
interneurons (INs) [5–7]. These populations (MNs and
INs) contribute to locomotion either by directly innervat-
ing muscle or by playing a role in central pattern gener-
ator (CPG) circuitry [8–12]. By deriving ventral spinal
populations from ESCs or induced pluripotent stem cells,
we can better study these populations in culture and their
role in locomotion and reorganization after spinal cord
injury.
One ventral spinal population that may contribute to
reorganization after spinal cord injury is the commissural,istributed under the terms of the Creative Commons Attribution 4.0
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Nkx2.2+ p3 progenitor domain and express the transcrip-
tion factor Sim1 upon reaching the post-mitotic stage
[13]. They contribute to rhythm generation networks
within the spinal cord by playing a role in regulating left–
right alternation of gait and in balancing locomotor out-
puts [12, 14]. This population has been shown to cross
multiple spinal segments and synapse onto MNs and
other INs [12, 14]. During maturation, V3 INs separate
spatially during post-mitotic development and become re-
cruited during running or swimming behaviors [14]. Their
importance in locomotion makes V3 INs a key target to
better understand locomotor coordination and a potential
cell therapy candidate for functional recovery and local
reorganization after spinal cord injury. Unfortunately, the
isolation of primary V3 INs from mouse spinal cords is
not technically feasible, driving the need for an in vitro
method to generate them.
Neurons of the ventral spinal cord have been generated
from mouse ESCs by exposing embryoid bodies (EBs) to
sonic hedgehog (Shh) pathway agonists and retinoic acid
(RA) [3, 4]. Shh forms a dorsal–ventral gradient in the
neural tube during development and helps to establish the
five ventral spinal progenitor domains, which then mature
into post-mitotic spinal neurons [15–18]. RA from the lat-
eral somites acts as a caudalizing factor to impart spinal
identity [3, 19, 20]. The protocol to derive MNs from
ESCs uses relatively high RA and Shh concentrations to
induce spinal MNs [3, 4, 21]. To induce V3 INs, the p3
progenitor domain location was examined in relation to
the progenitor MN domain location. Being a more ventral
population, V3 INs sit closer to the floor plate and noto-
chord, and therefore would be exposed to increased Shh
signal strength and duration [22]. Additionally, being
further away from the lateral somites, V3 INs would be
exposed to lower RA concentrations. While V3 INs can be
generated via induction of mouse ESCs, the yield is rela-
tively low (~8 %) [7].
Unfortunately, ESC differentiation protocols generally
yield heterogeneous populations, and this heterogeneity
makes live cell identification and characterization diffi-
cult. Heterogeneity also negatively affects transplantation
– often generating teratomas and causing regression after
short-term improvements due to incomplete cell differen-
tiation or maturation [23–25]. Some methods to reduce
this heterogeneity include density-based centrifugation,
fluorescence-activated cell sorting (FACS), and use of
transgenic cell lines with antibiotic resistance. Density
gradient-based MN separation protocols have been used
to improve MN yield [26, 27]. However, V3 INs are similar
in size to many other IN populations, making isolation of
V3 INs from other spinal cells difficult. FACS requires ei-
ther a unique cell surface marker or genetic engineering
of a fluorescent marker to isolate pure populations [28],and it is slow for purification of cells that make up a small
percentage of the initial population (<10 %) [29]. FACS
also increases the risk for contaminated cultures and can
result in low viability for post-mitotic neurons. Anti-
biotic resistance has a long history within biology for
positive selection of desired traits and is much more
scalable compared to FACS. Additionally, once an anti-
biotic resistant cell line is generated, no specialized
equipment is required for cell isolation. Cell lines for
antibiotic resistance have been previously utilized for
the enrichment of neural lineage populations [30, 31].
Recently, our lab generated mouse ESC lines expressing
puromycin-N-acetyltransferase (PAC, a puromycin re-
sistance gene) for the positive selection of induced
neural progenitors and neuronal populations [21, 32].
In these cell lines, PAC was expressed either under
Olig2, a marker for progenitor MNs (pMNs), or Hb9, a
marker for post-mitotic MNs. These cell lines utilized
drug selection as a high throughput, low cost method
to enrich cell populations for the desired cell type based
on developmental marker expression. We hypothesized
that incorporating PAC into the Sim1 locus would allow
for the enrichment of a previously reported V3 IN induc-
tion via antibiotic selection. The selected cells should
allow for the studying of V3 INs in vitro, including the
confirmation of Sim1+ cells’ glutamatergic identity.
Methods
ESC culture
This work involved no animals and only ESCs and
ESC-derived cell types. All ESCs were cultured on T-25
flasks coated in 0.1 % gelatin (Sigma, St. Louis, MO).
Cells were cultured in complete media consisting of
Dulbecco’s Modified Eagle Medium (DMEM 11965,
Life Technologies, Carlsbad, CA) containing 10 % new-
born calf serum (Life Technologies), 10 % fetal bovine
serum (Life Technologies), and a 1:100 dilution of a
100× nucleoside mix (EMD Millipore, Bellerica, MA).
Cells were routinely passaged by washing with DMEM
11965 containing 25 mM HEPES (Life Technologies),
dissociating with 1 mL 0.25 % Trypsin Ethylenedi-
aminetetraacetic acid (EDTA; Life Technologies),
quenching with complete media, and plating into a new
T-25 gelatin-coated flask containing a final volume of
5 mL media with 1000 U/mL leukemia inhibitory factor
(EMD Millipore) and 100 μM β-mercaptoethanol (Life
Technologies).
Generation of Sim1-Puro-pStartTK targeting vector
The Sim1-Puro-pStartTK targeting vector was con-
structed following a previously published protocol [33].
The backbone was a Gateway-compatible plasmid,
pStartK (Addgene, Cambridge, MA). Sim1 homology arms
were incorporated into pStartK from RP23-223 M2 BAC
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Research Institute, Oakland, CA) using pstartK_Sim1_up-
stream and pstartK_Sim1_downstream primers (Table 1)
by recombineering techniques with red recombinase com-
petent bacteria (Sim1-pStartK, Fig. 1a). A chlorampheni-
col resistance gene flanked by AscI cut sites from pkD3
(The E. Coli Genetic Stock Center, Yale University, New
Haven, CT) was inserted into the open reading frame of
the Sim1 gene by recombineering with primers Sim1_-
CAT_Forward and Sim1_CAT_Reverse 900 bp (Table 1).
The chloramphenicol resistance gene was then replaced
via restriction enzyme digestion and ligation by a dual
resistance cassette consisting of, from 5’ to 3’: Asc1 cut
site, Kozak sequence, PAC with bgh polyA signal, floxed
phosphoglycerate kinase I promoter driving neomycin
phosphotransferase (PGK-neo) with bgh polyA signal,
and AscI site (gift from Dr. David Gottlieb, Washington
University, St. Louis, MO) [21]. A negative selection
thymidine kinase gene was incorporated into the fin-
ished vector (Sim1-Puro-pStartTK, Fig. 1b) using pWS-
TK3 plasmid (Addgene) and Gateway LR clonase II kit
(Life Technologies). For a more detailed diagrams of the
recombineering steps, see Additional file 1: Figure S1.
Generation of Sim1-Puro ESCs
The Sim1-Puro cell line was generated from the RW4
mouse ESC line (American Type Culture Collection,
Manassas, VA). Approximately 1 × 107 RW4 ESCs were
resuspended in electroporation buffer with 10 μg of
Sim1-Puro-pStartTK vector and 200–300 ng of a Cas9
guide RNA vector (deemed gSim1.MS8.mSim1.g6a, with
guide RNA (Fig. 1c, Cas9 Guide RNA) targeting 5’-gtccat
cattcgtgtcttcc cgg-3’ near the Sim1 start codon (Fig. 1c,
Cas9 Target)) in the MLM3636 plasmid (Addgene plasmid
#43860) and 200–300 ng of the Cas9 nuclease expression
plasmid p3s-Cas9HC (Addgene plasmid #43945). Both
Cas9 vectors were obtained from Genome Engineering
Core, Washington University in St. Louis and originally
gifted by Keith Joung and Jin-Soo Kim, respectively. Cells
were electroporated using a Biorad Gene Pulser Xcell
Eukaryotic System at 0.23 kV and 975 μF in a 0.4 cm cu-
vette (Bio-Rad, Hercules, CA). Following electroporation,





Sim1_CAT_Reverse 900 bp TTGAGGAAGGGTGAGCAAATGGGAG
Sim1_Fwd_Junction1 atgcacacgactcttcaaagaa
Puro_Reverse Junction1 gcgccaggaggccttccatctgttgct
Capital letters indicate homology arms for red recombination24 hours then treated with G418 (200 μg/mL, Life Tech-
nologies) and 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-
5-iodouracil (150 nM, Movarek Biochemicals, Brea, CA)
for positive and negative selection, respectively. After
14 days, surviving clones were picked and seeded into in-
dividual wells of a gelatin-coated 96 well plate.
PCR screening on Sim1-Puro clones
Clones were screened for targeting events by junction
polymerase chain reaction (JPCR, Fig. 1d). One primer
binding outside of the left homology arm (5’ HA, Fig. 1d)
and the other primer binding inside the PAC gene were
used to screen for clones that properly incorporated the
PAC gene. Reactions were performed using a Mastercycler
Nexus Gradient thermocycler (Eppendorf, Hauppauge,
NY) with primers Sim1_Fwd_Junction1 and Puro_Reverse
Junction1 (Table 1 and Fig. 1d) at 95 °C for 60s,
followed by 35 cycles of 94 °C for 20s, 60 °C for 30s,
and 72 °C for 120 s.
Copy number assay
Taqman Copy number assay (Life Technologies) was
performed on cell lysates as per manufacturer instruc-
tions. Gapdh (Mm00186825_cn, Life Technologies) was
normalized to RW4 ESCs, and PAC (custom ordered
PAC assay, Life Technologies) was normalized to a pre-
viously published Hb9-Puro cell line [32]. Analysis was
performed using Life Technologies CopyCaller v2.0.
V3 IN induction
RW4 ESCs and Sim1-Puro ESCs were aggregated to form
EBs on a non-adhesive agar-coated surface and induced to
generate neural progenitors using our previously estab-
lished 8-day induction protocol (2−/6+, where “2−” refers
to the number of days ESCs are allowed to aggregate into
EBs without (−) RA and smoothened agonist (SAG, a Shh
pathway agonist) and “#+”refers to the number of days the
EBs are exposed to (+) RA and SAG; Fig. 2a) [7]. Cells
were cultured in suspension for 2 days on 100 mm Petri
dishes pre-coated with 0.1 % agar (Thermo Fisher Scien-
tific, Waltham, MA) in DFK-5 media comprised of 1:1
DMEM/F12 (Life Technologies) with 5 % knockout serum




Fig. 1 Generation and identification of Sim1-Puro cell line. a Red recombineering was utilized to insert the region approximately 2 kb upstream
to 10 kb downstream of Exon 1 of the Sim1 gene from RP23-223 M2 BAC into the pStartK backbone, generating the Sim1-pStartK plasmid. b After
AscI cut sites were introduced by another red recombination reaction, a PAC-PGK-Neo cassette was inserted into the open reading frame of Sim1
Exon1in the Sim1-pStartK plasmid. Using gateway recombination, the pStartK backbone was replaced with the pWS-TK3 backbone to introduce
the negative selection gene, TK. 5’ and 3’ homology arms are labeled. c CRISPR/Cas9 targeting of the Sim1 gene was used to generate a double
stranded break at the desired recombination location. Sim1-Puro-pStartTK recombined into the Sim1 locus as shown by the dotted lines. 5’ and 3’
homology arms are labeled. d The Sim1-Puro cell line with PAC in Sim1 Exon 1. Junction PCR (JPCR) primer for approximately 2.6 kb was used to
screen for the desired recombination event. e JPCR bands of positive (+) and negative (−) clones with a 1 kb ladder. f Copy number assay shows
Sim1 clones have one copy of PAC by comparison with RW4 ESCs (0 copy) and Hb9-Puro ESC (1 copy) controls. AMP, Ampicillin resistance gene;
AscI, Restriction enzyme site; attB1 & attB2, Gateway recombination results; HA, Homology arm; JPCR, Junction PCR; ori, Origin of replication; PAC,
Puromycin resistance gene; PGK, Phosphoglycerate kinase promoter sequence; Neo, Neomycin resistance gene; Sim1 ATG, Translation start in
Sim1 Exon1; TK, Thymidine kinase
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50 μM non-essential amino acids (Life Technologies), and
a 1:200 dilution of a 100× nucleoside mix. During the first
2 days, the cells aggregated into multi-cellular EBs. After
aggregation, EBs were removed and allowed to settle. The
supernatant was discarded and replaced with new DFK-5
media supplemented with 10 mM RA (Sigma) and 0.5 μM
SAG (EMD, Millipore). Media was replaced every 2 days
for 6 days.
Selection and differentiation of V3 INs
To test PAC expression in Sim1+ cells, RW4 and Sim1-
Puro EBs were subjected to induction and selection proto-
cols as illustrated in Fig. 2a. On 2−/4+, standard tissue cul-
ture plates were pre-coated with 0.01 % poly(ornithine)
solution (Sigma) at 37 °C for 1 hour. Poly(ornithine) wasremoved and plates were washed with a HEPES buff-
ered saline solution three times. Plates were then
coated with 0.01 mg/mL laminin (Life Technologies) in
HEPES buffered saline solution overnight and washed
three times before use as laminin coated plates. One
day prior to the end of V3 IN induction (on 2−/5+), EBs
were allowed to settle, and the DFK-5 media super-
natant was collected. EBs were dissociated with 0.25 %
trypsin-EDTA for 15 minutes at 37 °C, quenched with
complete media, pelleted and replated at 3.5 × 107 cells/
cm2 onto laminin-coated plates. Cells were incubated
with 2 μg/mL puromycin (Sigma) in the collected DFK-
5 supernatant for 1 day (designated as 1p, Fig. 2a). After
one day, puromycin-containing media was removed
and replaced with “P-Olig2-conditioned” media (see
next section) with supplemental factors (1× Glutamax
Fig. 2 The effect of selection on survival of RW4 and Sim1-Puro embryonic stem cells (ESCs). a Diagram depicting induction and selection process.
Induction and differentiation nomenclature is indicated by parenthesis while the time course (in days) is denoted by the time line. Briefly, ESCs are
allowed to aggregate for 2 days (2−) to form embryoid bodies (EBs). EBs are induced with retinoic acid (RA) and sonic hedgehog (Shh) for 5 days (5+)
and selected with puromycin in the presence of RA and Shh for 1 day (6+/ 1p). Selected cells are allowed to differentiate after selection (1p + #). b & d
Live (calcein-AM) staining on unselected cells. c & e Live staining of selected cells. Scale bar = 50 μm
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and BDNF (all from Peprotech, Rock Hill, NJ). Cells
were allowed to differentiate up to 14 days (designed as
“+ #” where # is the number of days after selection,
Fig. 2a).
Generation of P-Olig2-conditioned V3 media for long-term
V3 cultures
After selection, cells were initially cultured in a 1:1 mix
of DFK-5 and Neurobasal (Life Technologies) media
with supplemental factors (listed above). However, due
to the low cell density, extensive cell death was observed
between 3 and 7 days post-selection (1p +3 and 1p +7).
Thus, to improve cell survival, conditioned media gener-
ated by progenitor motor neuron cultures containing
glia (oligodendrocyte and astrocytes) were used. A
puromycin-selectable-pMN ESC line (P-Olig2), with
PAC knocked into the Olig2 locus, underwent 2−/4+ in-
duction using DFK-5 media with 2 μM RA and 0.5 μM
SAG (2 days without and 4 days with RA/SAG) as previ-
ously described [21]. On the last 2 days of pMN induc-
tion (2−/2+ – 2−/4+), cells were selected with 4 μg/mL
puromycin. On 2−/4+, the selected EBs were dissociatedand plated at a density of 100,000 cells/mL in a 1:1 mix of
DFK-5 and Neurobasal media with 1× B27 (Life Tech-
nologies) in a 6-well laminin-coated plate. Conditioned
media was collected and replaced with fresh media every
2 days. Selected P-Olig2 cells were cultured up to 14 days.
Live assay
Live reagent, calcein-AM (Life Technologies), was used
to visualize live cells, respectively. Wells were washed
with DMEM 11965 containing 25 mM HEPES and incu-
bated with 0.325 μL/mL of 4 mM stock concentration
calcein-AM (live) for 30 min at room temperature.
Probe synthesis for in situ hybridization
Plasmids for in situ hybridization probes were a gener-
ous gift from Dr. Paul Gray (Washington University in
St. Louis) [34]. Gene fragments from verified plasmids
were linearized by direct PCR amplification using
ReadyMade Primers (SP6 Promoter and T7 Promoter,
Integrated DNA Technologies, Coralville, IA). Digoxi-
genin (DIG)-labeled antisense and sense RNA probes
were made using PCR products as templates and T7 RNA
polymerases (Roche, Indianapolis, IN). Probes were used
Table 2 TaqMan Gene Expression Assays for qRT-PCR
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probes were tested to ensure probe specificity.
In situ hybridization
To assess the purity of cells post-selection, in situ
hybridization was performed on dissociated cells. After
24 hours of selection, cultured cells were fixed in 4 %
paraformaldehyde (PFA) for 10 minutes and washed three
times in diethylpyrocarbonate-treated phosphate buffered
saline (PBS; Sigma) at room temperature. Next, cells were
incubated in 0.1 M triethanolamine-HCl (1.3 % triethanol
amine (Sigma) and 0.4 % HCl (Thermo Fisher Scientific)
with 0.25 % acetic anhydride (Sigma)) for 10 minutes.
Cells were washed in 1× sodium citrate buffer for 5 mi-
nutes at room temperature and permeabilized in 0.2 M
HCl in diethylpyrocarbonate-water for 10 minutes. Three
additional washes with diethylpyrocarbonate-treated PBS
were performed before cells were blocked in hybridization
buffer (50 % formaldehyde (Sigma), 5× sodium citrate buf-
fer (SSC, Life Technologies), 0.3 mg/mL yeast RNA
(Sigma), 0.1 mg/mL heparin (Sigma), 1× Denhardt’s solu-
tion (Life Technologies), 0.1 % tween (Sigma), and 5 mM
EDTA) for 4–6 hours at room temperature. Cells were
incubated in hybridization buffer containing 1–2 μg/mL
DIG-labeled antisense RNA probes (see previous sec-
tion) overnight at 65 °C. Probed cells were washed
twice in 0.2× SSC at 62 °C, and incubated in 0.2× SSC
for 60 minutes at 65 °C. Washed cells were adjusted to
room temperature and blocked with 10 % deactivated
horse serum (Life Technologies) in PBS with 2 mg/mL
bovine serum albumin and 0.1 % Triton X-100 (PBT)
and incubated in alkaline phosphatase-labeled anti-DIG
antibody (1:2000 in 10 % deactivated horse serum in PBT;
Roche) overnight. Cells were further washed with PBT
and color was visualized using nitro blue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate (Roche). Staining
was stopped with 4 % PFA after visual inspection. Cell
nuclei were stained with the nuclei binding dye Hoechst
(1:1000, Life Technologies).
Immunocytochemistry
Neuronal cell identity was assessed in differentiated cul-
tures using immunocytochemistry. Cell cultures were
fixed with 4 % PFA for 30 min then permeabilized in
0.01 % Triton X (Sigma) for 15 min. The cells were
blocked with 5 % normal goat serum for 1 hour at 4 °C
and incubated overnight at 4 °C in 2 % normal goat
serum solution with one or more of the following pri-
mary antibodies: rabbit anti-Tuj1 (for β-III tubulin,
1:200, Covance, Princeton, NJ), guinea pig anti-VGluT2
(1:3000, EMD Millipore), mouse anti-SV2 (1:100, Devel-
opmental Studies Hybridoma Bank, Iowa City, IA),
rabbit anti-MAP2 (1:1000, EMD Millipore), mouse anti-
bassoon (1:600, Enzo Life Sciences, Farmingdale, NY),mouse anti-Isl1 (1:100, Developmental Studies Hybridoma
Bank), mouse anti-Hb9 (1:20, Developmental Studies
Hybridoma Bank), mouse anti-A2B5 (1:25, Developmental
Studies Hybridoma Bank), mouse anti-nestin (1:100,
Developmental Studies Hybridoma Bank), mouse anti-
Nkx2.2 (1:100, Developmental Studies Hybridoma Bank),
rabbit anti-Ki-67 (1:100, Abcam, Cambridge, MA), mouse
anti-O4 (1:100, EMD Millipore), and mouse anti-Uncx
(1:500, EMD Millipore). Primary antibody staining was
followed by three washes in an excess volume of PBS
for 15 min each. Each culture was then stained with
appropriate Alexa Fluor secondary antibodies (1:1000,
Life Technologies) for 1 hour at 4 °C followed by an
additional three washes in PBS. Cell nuclei were stained
with Hoechst (1:1000, Life Technologies).
Image capture and analysis
All images were captured using a MICROfire camera
(Olympus, Center Valley, PA) attached to an Olympus
IX70 inverted microscope using either a 10× or 20×
objective. Images were merged and colored using ImageJ
(US National Institutes of Health, Bethesda, MA). To
remove human bias, ImageJ was used for the automated
counting of Hoechst-labeled nuclei. Images underwent
thresholding to remove background and were then con-
verted to binary black and white images. The “Analyze
Particles” function was used to count the nuclei, exclud-
ing any small (less than 600 pixels) punctate nuclei to
prevent apoptotic Hoechst+ nuclear debris from being
counted.
Quantitative real-time PCR (qRT-PCR)
Fourteen days after selection (1p +14), selected and unse-
lected (control) cells on a 24-well plate were lysed with
350 μL of buffer RLT from the RNeasy Mini Kit (Qiagen,
Valencia, CA). High Capacity RNA-to-cDNA Kit (Life
Technologies) generated cDNA from RNA that was ex-
tracted per Qiagen’s instructions. TaqMan Fast Advanced
Master Mix (Life Technologies) was combined with
TaqMan Gene Expression Assays (Life Technologies;
Table 2) and cDNA for qRT-PCR. Reactions were per-
formed using a Step One Plus Applied Biosystems ther-
mocycler (Life Techonologies) with the default protocol:
95 °C for 20 s, 40 cycles of 95 °C for 1 s and 60 °C for 20 s.
The number of cycles necessary for the fluorescent
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corded and normalized to β-actin expression. The com-
parative ΔCt method [35] was used to analyze the mRNA
expression levels compared to undifferentiated Sim1-Puro
ESCs. Fold differences in relative mRNA expression levels
over the control cultures are reported for each gene (n ≥3
for all groups).
Electrophysiology
Whole-cell electrodes had an open tip resistance of 2–6
MOhms when filled with K- or Cs-glucuronate internal
solutions (in mM, all from Sigma): 140 K-glucuronate 10
NaCl, 5 MgCl2, 0.2 EGTA, 10 HEPES, pH adjusted to
7.4 with KOH; or, 130 Cs-glucuronate, 5 MgCl2, 0.2
EGTA, 10 HEPES, pH adjusted to 7.4 with CsOH. Both
internal solutions were supplemented with 5 mM Na-
ATP and 1 mM Na-GTP. Culture dishes were perfused
at approximately 1 mL/min with Tyrode’s solution (in
mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10
HEPES, pH adjusted to 7.4 with NaOH. Currents and
membrane potentials were recorded with Axopatch 200
amplifiers (Molecular Devices, Sunnyvale, CA), filtered
at 1 kHz and digitized at 10 kHz using pClamp 9.2 (Mo-
lecular Devices, Sunnyvale, CA). Tetrodotoxin (0.5 μM),
tetraethylammonium (30 mM), and 4-aminopyridine
(5 mM) were dissolved in Tyrode’s solution. Agonists
were dissolved at 100 μM in 160 mM NaCl, 2 mM
CaCl2, 10 mM HEPES, pH adjusted to 7.4 with NaOH.
Drug solutions were applied by local perfusion from a
multi-barreled delivery pipette [6].
Statistical analysis
Three biological replicates of each condition were per-
formed. Three sample pictures were analyzed from
each replicate for cell counting. Statistical analysis was
performed in Statistica software (version 5.5; StatSoft,
Tulsa, OK). Unless otherwise stated, multiple compari-
son statistics were accomplished using Scheffe’s post
hoc test for analysis of variance (ANOVA) with a 95 %
confidence level. Values are reported as the mean plus
or minus standard deviation.
Results and discussion
While ESCs provide a plentiful cell source to better
study a variety of cell types, the heterogeneity of cells in-
duced from ESC cultures by current protocols retains
the problems of dissection and isolation. Recently, our
lab reported a MN line where previously established
Hb9 enhancer regions were used to drive expression
PAC [32]. Unfortunately, a highly conserved efficient en-
hancer region for Sim1 has not been identified [36].
Thus, random insertion of a Sim1 enhancer-promoter
driving PAC was not achievable. Homologous recombin-
ation has been used ubiquitously to generate knockoutanimals and cell lines [33]. Previously, our lab reported
an Olig2-Puro cell line that has PAC knocked into the
Olig2 locus, enabling the Olig2 gene regulatory elements
to control PAC expression [21]. This method was
adopted for the Sim1 locus, such that transgenic mouse
ESCs were generated by the electroporation of a vector
containing the PAC gene into the Sim1 locus. The use of
Cas9/CRISPR technology greatly increased the efficiency
of recombination by inducing a double strained break in
the first exon of Sim1. This paper describes a method to
overcome the heterogeneity of ESC-derived V3 IN cul-
tures using this Sim1-Puro ESC line. The generated cell
line would not be used clinically, but would serve as a
tool for furthering understanding of V3 INs through
in vitro and in vivo studies in rodent models of spinal
cord injury.
Targeted PAC insertion into the Sim1 locus
The Sim1-Puro cell line was generated by using a target-
ing vector to insert a resistance cassette into the open
reading frame of the Sim1 gene. Two homology arms
approximately 2 kb and 10 kb in size were inserted into
the targeting vector flanking the resistance cassette
(Fig. 1a,b). RW4 ESCs were electroporated with the
targeting vector and a set of Sim1 targeting Cas9/
CRISPR plasmids. The expected homologous recombin-
ation event is illustrated in Fig. 1c. JPCR with one primer
hybridizing to genomic DNA outside of the homology
arms and one primer hybridizing within the resistance
cassette was used to screen for insertion of the resistance
cassette into the Sim1 locus (Fig. 1d,e).
While Sim1-Cre heterozygous animals have been re-
ported with appropriate neuronal migration, in Sim1
knockout mice, the neurons fail to properly migrate
[37]. Furthermore, Sim1–/– animals are not viable [37],
further indicating the importance of keeping at least one
allele of Sim1 intact. Thus, it was important that only
one allele had the puromycin gene knocked into the
Sim1 locus. Two clones (6E and 8E) that screened posi-
tive for insertion of PAC by JPCR were analyzed with a
copy number assay, which reported values of approxi-
mately 1 for both clones (Fig. 1f ), indicating that only
one copy of the PAC gene was inserted into the cells,
and that the other Sim1 allele did not have PAC knocked
in. The appropriate JPCR results coupled with the copy
number assay results together indicate that one copy of
PAC was successfully inserted into the Sim1 locus,
resulting in the desired Sim1-Puro cell line. The result-
ing transgenic-ES cell line (Sim1-Puro Clone 6E) was
used for all subsequent studies.
Increased purity of Sim1+ cells after puromycin selection
To test for PAC expression in Sim1+ cells, RW4 and
Sim1-Puro EBs were subjected to induction and selection
Xu et al. Stem Cell Research & Therapy  (2015) 6:220 Page 8 of 17(2−/6+/1p) protocols as illustrated in Fig. 2a. Visual assess-
ment of calcein-AM staining of selected and unselected
cultures showed that 2 μg/mL puromycin was sufficient to
kill all RW4 cells. The unselected RW4 culture (Fig. 2b)
looked healthy and confluent, while the selected RW4s
had no remaining live cells (Fig. 2c). In the Sim1-Puro se-
lected and unselected cultures, the unselected cultures
contained many cells of non-neuronal morphology, while
the selected culture contained fewer cells with non-
neuronal morphology (Fig. 2d,e). The efficacy of RW4
selection indicated that the 2 μg/mL puromycin concen-
tration had sufficient potency to remove all non-PAC-
expressing cells but allowed survival of PAC-expressing
cells, whereas 4 μg/mL puromycin resulted in very low
cell viability (data not shown). Thus, 2 μg/mL puromycin
was used for subsequent studies.
Due to the lack of a specific Sim1 antibody, the purity
of cultures post-selection was assessed by performing
in situ hybridization on dissociated cultures. The per-
centage of Sim1+ cells increased significantly from 11 %
in unselected cultures to 83 % after selection (Fig. 3).
This increase indicated that puromycin selection of the
Sim1-Puro line successfully enriched for Sim1+ cells.
Furthermore, the presence of Sim1+ cells via in situFig. 3 Puromycin selection increases the percentage of cells expressing Sim1
and nuclear staining (blue) on unselected cells. d–f Sim1 in situ hybridiza
hybridization. b & e Nuclear marker Hoechst (blue). c & f Overlaid images
P <0.05 compared to unselected grouphybridization corroborates the copy number assay data
and suggests that the Sim1 gene on the non-altered al-
lele should be functional, at least to the properly spliced
mRNA stage. In addition to looking for Sim1+ cells, we
also assessed the selected and unselected cultures for
Uncx (a V3 marker) and Nkx2.2 (a p3 marker) expres-
sion. As seen in Additional file 2: Figure S2, we saw an
increase in the percentage of cells expressing Uncx
(from 20.1 ± 1.7 in the unselected culture to 43.8 ± 4.1
in the selected culture) and no change in the percent-
age of cells expressing Nkx2.2. This also points to an
enrichment of V3 INs in the selected culture.
To assess what other cell types were present after se-
lection, cultures were stained with Hb9, Isl1, Ki67,
A2B5, and nestin (Additional file 2: Figure S2). Com-
pared to the unselected cultures, the selected cultures
showed a decrease in non-V3 lineage markers. These re-
sults indicate that the cells surviving selection contained
predominantly the desired cell type.
Based on the in situ hybridization and immunocyto-
chemistry results, the Sim1-Puro cell line is able to enrich
a culture for Sim1+ cells, such that most of the cells in a
selected culture are Sim1+. The purity of the selected
Sim1-Puro line is lower compared to the 99 % purity ofin Sim1-Puro cultures. a–c Sim1 in situ hybridization (dark cell bodies)
tion and nuclear staining on selected cells. a & d Sim1 in situ
. g Selected cultures enriches for percentage of Sim1+ cells. * Denotes
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ated in our lab [32]. One reason for lower purity is that
the Hb9-Puro line was assessed with an antibody while
the Sim1-Puro line was assessed with in situ hybridization
– an mRNA based technique. Because mRNA is transient
and expressed prior to protein synthesis, a portion of the
surviving cells could be Sim1 mRNA-negative but have re-
cently expressed Sim1 mRNA and thus still have Sim1
and PAC protein present. They would not be Sim1+ by in
situ hybridization, but would still be V3 INs and might
stain positive with a Sim1 antibody, if one existed. The
immunocytochemistry data for MNs and glia showed a
scarcity in the MN population and some glia population,
suggesting that the selected culture consists mostly of V3
INs. Furthermore, the increase of the percentage of cells
staining positive for Uncx, from 20.1 % of cells in unse-
lected cultures to 43.8 % of cells in the selected cultures,
showed that V3 INs were indeed enriched. The disparity
between the percentage of cells expressing Uncx protein
(43.8 %) versus Sim1 mRNA (82.8 %) could be due to vari-
ations of the Sim1 and Uncx expression time course or
mRNA being expressed at earlier time points versus pro-
tein. Furthermore, the combination of percent selected
cells expressing Uncx (43.8 %) and Nkx2.2 (31.6 %) did
sum to be much closer to the percentage of Sim1+ cells,
suggesting that Uncx may be expressed slightly later than
Sim1 and that cells lacking Uncx expression are still
Nkx2.2 positive. Unfortunately, because the Uncx and
Nkx2.2 antibodies are both mouse IgG antibodies, we
were unable to co-stain with these two markers.
Another reason for having a lower percentage of Sim1+
cells is that, compared to the Hb9-Puro study, a lower
puromycin concentration was used in this study for selec-
tion. Previously, 4 μg/mL puromycin was used for the
Hb9-Puro cell line [32] and 2 μg/mL was used here with
the Sim1-Puro cell line since less than 100 cells/cm2 were
observed after 4 μg/mL puromycin selection (versus
50,000–100,000 cells/cm2 for 2 μg/mL puromycin). It was
previously reported that Hb9 mRNA levels increase ap-
proximately 400-fold versus uninduced controls (no RA
and no SAG) after MN induction, whereas Sim1 mRNA
levels only increase approximately 100-fold after induction
[7, 21], suggesting that Sim1 is not as strongly expressed
as Hb9. This fold change difference can be partially attrib-
uted to the lower induction protocol efficiency (~60 % for
MNs vs. ~10 % for V3 INs), but it could also be due to
Sim1 gene regulatory elements driving less robust expres-
sion than those for Hb9. Lower levels of PAC expression
in each cell could result in increased sensitivity at a lower
puromycin concentration. The relatively low purity of the
selected Sim1-Puro cell line could be a problem for longer
term studies. While we were able to observe distinct neur-
onal morphology up to 2 weeks post-selection, the pres-
ence of proliferation marker Ki-67 in our culture indicatesthat, in time, glia may overwhelm V3 INs. Furthermore,
glia survival will limit the control we have in defining cell
ratios of seeded cell types in any co-cultures or in in vivo
transplantation studies moving forward. While the result-
ing cultures are not 100 % Sim1+ cells, the observed
enrichment is sufficient to allow for further studies of
ESC-induced V3 INs.
Selected cultures exhibit neuronal markers and achieve
functional maturity
Glial-conditioned media was needed for the long-term
survival of selected Sim1-Puro V3 INs. Initially, without
conditioned media, we observed axonal degeneration by
7 days in culture and ultimately cell death. We hypothe-
sized that providing glial signaling cues would aid in V3
IN survival. Thus, the P-Olig2 ESC line, where the PAC
gene was incorporated into the Olig2 locus was used to
obtain glia and to produce conditioned media. Selection
of P-Olig2 cells results in both MNs and glia (oligoden-
drocytes and astrocytes) [21]. While this was not ideal
for generating a high purity MN population, the result-
ing pMN population generated glial-conditioned media
suitable for long-term cultures of V3 INs. Using this
conditioned media, V3 IN cultures survived for more
than 14 days, which was necessary for maturation and
synapse formation to be observed.
To assess the phenotype selected cultures, immuno-
cytochemistry was performed. β-III tubulin was used to
verify the neuronal identity of the selected cells. As seen
in Figure 4a and e, selected cells express β-III tubulin
with axonal morphology at both 3 and 7 days post-
selection (1p +3 and 1p +7). VGluT2, a vesicular glutam-
ate transporter found in synaptic vesicles at presynaptic
nerve terminals of excitatory neurons, was used as a
marker of glutamatergic neurons. As seen in Figure 4b
and f, selected cells exhibited punctate VGluT2 staining
along their axons at 3 and 7 days post-selection. The
VGluT2 and β-III tubulin staining aligned well (Fig. 4c,d),
and the VGluT2 puncta are clearly visible in the zoomed
in insets (Fig. 4g,h). These two antibodies verify that the
selected cells are indeed glutamatergic neurons. To
characterize the 1p +7 cultures further, proliferation
marker Ki-67 and oligodendrocyte marker O4 were
quantified along with β-III tubulin as a percentage of
total cells (Additional file 2: Figure S2C). Only a few per-
cent of the cells expressed Ki-67 and O4, suggesting that
glia overtake of the culture did not occur.
Because these images were taken 4 days apart, some
disparities between the left and right columns of Figure 4
were expected. We expected to observe maturation of
axonal processes (longer axons and more connectivity be-
tween each other), which can be observed in Figure 4g.
Furthermore, at 7 days post-selection, the cells are more
sparsely distributed. This is not unexpected due to pruning
Fig. 4 Sim1-Puro cultures exhibit glutamatergic and neuronal markers through the first week post-selection. a–d Staining 3 days post-selection.
e–h Staining 7 days post-selection. Immunocytochemistry marker labeled on far left. a & e β-III tubulin (red in combined); b & f VGluT2 (green in
combined); c & g Combined image; d & h Zoomed in combined image. Scale bar = 100 μm
Xu et al. Stem Cell Research & Therapy  (2015) 6:220 Page 10 of 17observed in neuronal development. While some debate
exists in the literature over whether INs undergo apop-
tosis as observed in MNs, it has been shown that ventral
spinal INs do undergo apoptosis after they become post-
mitotic [37, 38]. This occurs generally between e14 and P0
[37]. Our induction ends (1p +0) when Sim1 is strongly
expressed, roughly equivalent to e11.5 [39], so apoptosis
would be expected in the ensuing week. Taken together,
the differences between the left and right columns of Fig-
ure 4 are consistent with expected neuronal maturation.
To determine whether selected V3 INs are maturing,
immunocytochemistry was performed on cultures 2 weeks
post-selection. MAP2, a dendritic marker, was used to
identify neurons in culture. SV2 and Bassoon stainingshows positive, punctate, synaptic marker staining along
axons, indicating potential synapse formation (Fig. 5a–f ).
The presence of positive synaptic marker staining within
the cell body was not expected. We hypothesized that if
the synaptic marker mRNA was still being expressed, pro-
tein translation could be in progress and result in positive
staining of the cell body. Thus, qRT-PCR was performed
on 1p +14 (2 weeks post-selection) to assess expression
levels of synaptic markers. Synaptic markers SV2, Bas-
soon, and PSD95, as well as glutamatergic neuron marker,
VGluT2, were assessed in selected and unselected cul-
tures. The resulting qRT-PCR data shows an upregulation
of all markers in all conditions compared to the ESC con-
trols and an increase in all marker expression between
Fig. 5 Sim1-Puro cultures exhibit synaptic marker protein and mRNA expression after 2 weeks. a–f Two-week selected cultures stained with dendritic
marker MAP2 and synaptic markers, SV2 and Bassoon. Synaptic markers (b and e, red) exhibit puncta that overlap with MAP2 (c and f, white arrows)
suggesting synapse formation. Scale bar = 50 μm. g Two-week selected cultures express increased synaptic marker (Bassoon, PSD95, and SV2) and
VGluT2 (glutamatergic neuron) mRNA levels compared to unselected cultures (normalization control – Sim1-Puro ESCs). * Denotes P <0.05 compared
to the unselected group
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be considered within the context of a population-averaged
assay. While the results suggest that there are more cells
expressing synaptic markers in selected versus unselected
cultures, the data only indicate that in selected cultures
there is a greater percentage of neurons than in unselected
ones. This is due to normalization of the data to the in-
ternal control β-actin, effectively normalizing expression
levels to cell count. Additionally, the relative low levels ofsynaptic marker expression suggest that neurons within
the cultures at 2 weeks are working towards but have not
yet formed mature synapses.
Electrophysiology
In addition to using immunocytochemistry to characterize
the Sim1-Puro line, electrophysiological recordings of the
selected cells were also used to assess maturation. Whole-
cell electrodes were used to test for action potential
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and ligand-gated currents under voltage clamp. Record-
ings were obtained from more than 50 cells between 2
and 5 days after puromycin selection (1p +2 to 1p +5;
early) and more than 60 additional cells between 6 and
13 days post-selection (1p +6 to 1p +13; late). Cell capaci-
tance increased and input resistance decreased with time
after selection consistent with an increase in cell size
(Table 3). Resting membrane potential (Vrest) became
more negative with time as did the proportion of cells that
maintained Vrest less than −50 mV without the need for
DC hyperpolarization. As shown in Figure 6, depolarizing
current injection elicited action potentials in cells as
early as 2 days after puromycin selection. With DC hy-
perpolarization to −60 mV and long duration (800 msec)
depolarizing current pulses, all 14 of the early (1p +2 to
1p +5) cells tested were able to fire multiple action po-
tentials, 57 % showed prominent spike adaptation, and
the remaining 43 % fired repetitively with little adaptation.Table 3 Electrophysiological properties of Sim1-Puro selected
cells
Parameter 1p +2–5 1p +6–13
Capacitance (pF) 18.3 ± 1.3 (51) 24.2 ± 0.9 (68)a
Input Resistance (GOhm) 1.64 ± 0.49 (51) 0.96 ± 0.17 (68)a
V rest (mV) −28.5 ± 2.1 (43) −43.7 ± 1.2 (64)a
% V rest less than −50 mV 5 % 28 %a
Rheobase (pA) 10.6 ± 2.3 (14) 18.3 ± 2.7 (34)
1st spike latency (msec) 214 ± 43 (14) 153 ± 19 (24)
1st spike amplitude (mV) 84 ± 4.5 (14) 95 ± 3.5 (24)
absolute amplitude (mV) 23 ± 4.1 (14) 34 ± 3.5 (24)
1st spike threshold (mv) −32.4 ± 0.8 (14) −35.1 ± 1.0 (24)
1st spike width (msec) 4.4 ± 0.5 (14) 2.9 ± 0.3 (24)a
10 Hz 1st latency (msec) 44 ± 3.2 (14) 37 ± 2.0 (24)
10 Hz 1st frequency (Hz) 11 ± 0.3 (14) 12 ± 0.3 (24)a
10 Hz frequency adaptation 1.2 ± 0.04 (14) 1.3 ± 0.05 (24)
10 Hz after potential (mv) 0.9 ± 0.5 (14) −0.9 ± 0.7 (24)
f-I slope 1st interval 0.59 ± 0.07 (14) 0.44 ± 0.03 (24)
f-I slope average frequency 0.54 ± 0.07 (14) 0.36 ± 0.03 (24)
Sag at −90 mV (mV) 3.3 ± 1.1 (14) 3.3 ± 0.7 (24)
Peak I Na (nA) −1.06 ± 0.12 (40) −2.09 ± 0.16 (58)a
Vm for peak I Na (mV) −21.0 ± 1.6 (40) −26.1 ± 1.4 (58)a
Values presented as mean ± SEM (number of cells). aDenotes significantly
different from 1p +2–5 days by t-test, Mann–Whitney rank sum test, or Z-test.
Cell capacitance and input resistance were determined from 10 mV voltage
clamp steps from a holding potential of −80 mV. First spike latency, amplitude,
absolute amplitude, threshold and half-width were determined for the first spike
recorded at threshold depolarization. In addition, 800 msec depolarizations that
elicited spiking with an average frequency of 10 Hz were used to measure 1st
latency, instantaneous frequency from the first inter-spike interval (ISI), frequency
adaptation (ratio of last to first ISI), after potential as well as the initial slope of
frequency versus current (f-I) plots of instantaneous and average frequency. Sag
in voltage responses was determined for 800 msec hyperpolarizing current
injections from −60 mVMost late (1p +6 to 1p +13) cells (70 %) also fired multiple
spikes; however, 30 % only fired single action potentials.
For cells that produced multiple spikes the firing proper-
ties (Table 3) were more similar to the ventral than the
dorsal V3 interneuron population as characterized in
mouse spinal cord slices [14, 40].
Under voltage clamp, Sim1-Puro-selected cells exhib-
ited fast transient inward current and slow rising transi-
ent and sustained outward currents with depolarizing
voltage steps from a holding potential of −80 mV
(Fig. 6). Inward current was blocked by the selective
sodium channel antagonist, tetrodotoxin (0.5 μM).
Outward current was reduced in cells filled with the
potassium channel blocker cesium, or by extracellular
exposure to the organic potassium channel blockers,
tetraethylammonium (30 mM) and 4-aminopyrridine
(5 mM). As observed in other cell types [41], tetraethy-
lammonium inhibited sustained outward currents, while
4-aminopyrridine reduced transient outward current.
These results indicate the Sim1-Puro cells are expressing
functional ion channels and behave in an appropriate
manner for glutamatergic neurons.
Because mature V3 interneurons in acute slice record-
ings fire multiple spikes [14], we evaluated the relation-
ship between spiking phenotype and a number of
physiological parameters (Additional file 3: Figure S3).
Cells from days 6–13 that fired single action potentials
had a significantly higher rheobase than adapting or
multiple spiking cells. In addition, single-spiking cells
had the lowest mean ratio of inward to outward current,
although this difference was not significant. Taken to-
gether, the results in Additional file 3: Figure S3 suggest
that adapting and single spiking cells exhibit only minor
differences in their physiological properties, which may
be due to the in vitro environment in dissociated cell
culture or may reflect a bona fide difference between
ESC-derived and native neurons.
Selected Sim1-Puro cells expressed a number of
neurotransmitter-gated channels, as determined by ex-
posure to the inhibitory transmitters γ-aminobutyric
acid (GABA) and glycine, as well as excitatory agonists
for α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA)/kainate and N-methyl-D-aspartate (NMDA) re-
ceptors. Agonists were applied at 100 μM, and the NMDA
solution was supplemented with 1 μM glycine, which is
required as a co-agonist. At a fixed holding potential of
−80 mV, all four agonists evoked inward currents (Fig. 7a).
When the holding voltage was ramped from negative to
positive potentials, the currents reversed polarity consistent
with the ionic selectivity of their underlying ion channels.
Current evoked by GABA or glycine reversed near
−50 mV as expected for chloride selective channels,
whereas kainate and NMDA evoked currents that reversed
near zero mV, consistent with selective permeability to
Fig. 6 Sim1-Puro selected cultures exhibit action potential firing and voltage gated currents consistent with neuronal maturation. a Sub- and
supra-threshold voltage responses recorded under current clamp in a 1p +2 cell with 50 msec square pulse injection (6 and 8 pA). b Examples of
cells firing single (1p +11), adapting (1p +11), and multiple (1p +10) action potentials during an 800 msec depolarizing pulse (44 pA). c Currents
mediated by tetrodotoxin-sensitive sodium channels evoked by steps from −100 to +60 mV from a holding potential of −80 mV (below). Peak
inward current plotted as a function of step potential (1p +13; Cs-glucuronate internal solution). d Outward currents mediated by voltage-gated
potassium channels for steps from −100 to +60 mV from a holding potential of −80 mV recorded in 0.5 μM tetrodotoxin (TTX) alone and in TTX
plus 5 mM 4-aminopyrridine (4AP) (below). 4AP-sensitive currents revealed by subtracting current in TTX and 4AP from current in TTX alone
(1p +8, K-glucuronate internal solution). e Current–voltage relation for steady-state current recorded in TTX plus 4AP (open symbols) and for
peak 4AP-sensitive current (filled symbols)
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pressing appropriate neurotransmitter receptors.
The data presented indicates that selected cells exhib-
ited maturation by decreasing input resistance, increas-
ing membrane capacitance, and acquiring more negativeresting potentials. Inward and outward currents, appro-
priate agonist and blocker responses, and spike firing
and adaptation also point to the in vitro maturation of
the V3 INs. Additionally, the data presented within
Table 3 suggests similar trends as the values reported in
Fig. 7 Excitatory and inhibitory agonists activate appropriate
whole-cell currents in Sim1-Puro selected cultures. a Whole-cell
currents evoked by kainate (K), γ-aminobutyric acid (GABA), glycine
(Gly), and N-methyl-D-aspartate (NMDA, N; with 1 μM added
glycine). Holding potential, −80 mV. b Agonist-evoked currents
recorded during voltage ramps from −100 to +50 mV at 1.2 mV/
msec. GABA and Gly evoked a current that reversed polarity at
−48.6 ± 2.0 mV (n = 21) and −47.7 ± 2.2 mV (n = 10), respectively,
consistent with activation of channels selective for chloride. K and
NMDA evoked currents reversed at −1.4 ± 5.4 mV (n = 24) and −5.3
± 7.2 mV (n = 4), respectively, consistent with activation of cation
selective channels. c Currents increased with time in culture after
puromycin selection (n = 30 to 45 cells per bar). *Denotes P <0.01
(Mann–Whitney rank sum test)
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Puro V3 INs having capacitance and input resistance
values that fall fairly close to the error range previously
reported for the ventral V3 IN population. A few differ-
ences in the cells recorded in our study deserve men-
tion. Firstly, the ESC-derived V3 population is likely to
exhibit more rostral positional identity than the lumbar
populations studied by Borowska et al. [40]. The use of
low RA to derive V3 INs will result in a more rostral
phenotype [7] than the lumbar population analyzed in
earlier studies [14, 40]. Secondly, the values reported in
the literature for V3 INs were determined by recordings
from slices and not from neurons in dissociated cell
culture. The difference in environment may underlie
modest differences between our results and literature
reported data. Not only do the ESC-derived V3 INs
in vitro lack appropriate cues for migration, they are also
deprived of physiologically normal pre- and post-synaptic
connections. Thus, the slightly different than slice record-
ing measurements observed in isolated ESC-derived V3
INs are not unreasonable.
In addition to currents evoked by exposure to exogen-
ous agonists, some of the selected Sim1-Puro cells dis-
played spontaneous inward currents that resembled
excitatory postsynaptic currents observed in primary
neuronal culture (Fig. 8). The frequency of spontaneous
events increased substantially during local perfusion
with elevated KCl (10–20 mM) to depolarize presynaptic
terminals. Consistent with the glutamatergic phenotype
of V3 interneurons, spontaneous currents in selected
Sim1-Puro cultures were unaffected by the GABAA re-
ceptor antagonist, bicuculline (200 μM), but were elimi-
nated during superfusion with a combination of NBQX
(30 μM) and APV (50 μM), glutamate receptor antago-
nists that block AMPA/kainate and NMDA receptors,
respectively [42]. These observations of spontaneous
inward currents resembling postsynaptic currents func-
tionally confirms the glutamatergic phenotype expected
for V3 INs. Furthermore, these recordings at 1p +10
confirms the qRT-PCR data and indicates that selected
Fig. 8 Sim1-Puro-selected cultures present synaptic currents
consistent with glutamatergic neurons. a Whole-cell current re-
corded at −80 mV during exposure to Tyrode’s solution containing
elevated potassium (10 mM; KCl alone) as indicated by the open
box, or 10 mM potassium Tyrode’s that also included 30 μM NBQX
and 50 μM APV to block AMPA/kainate and NMDA receptors, re-
spectively, as indicated by the filled box. Short segments during
each exposure are shown on a 10-fold expanded time scale. b Plots
of mean ± sem amplitude (Amp, pA), frequency (freq, Hz), and width
at half amplitude (half-width, msec) of synaptic events evoked dur-
ing exposure to elevated KCl alone (open bars, four cells) or with
200 μM of the GABA antagonist bicuculline methiodide (grey bars,
three cells)
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glutamatergic neurons.
Conclusion
In this study, we have demonstrated that PAC was suc-
cessfully knocked into the Sim1 locus of a mouse ESC
line. The resulting cell line allows for the enrichment of
Sim1+ cells post-induction. The selected population ex-
hibits characteristics consistent with what is expected of
V3 INs at this stage of development. This novel cell line
allows for the further understanding of an understudied
population of spinal INs. It is, however, important to
keep in mind the limitations of this generated cell line.
First of all, this cell line is limited by the robustness of
the induction protocol. A low puromycin concentration
is used in the selection process to help improve V3 IN
yields after selection. This low puromycin concentration
resulted in a selected culture that is not 100 % pure. Sec-
ondly, due to difficulties in obtaining primary cultures,
we have not shown how our selected V3 IN cultures
compare to primary cells in vitro. Finally, the generatedcell line is not designed for use in a clinical setting due to
its transgenic and murine nature. However, the Sim1-Puro
cell line could be useful in understanding IN maturation
and CPG formation. Co-culturing Hb9-Puro MNs and
Sim1-Puro V3 INs could be a starting point for a bottom-
up approach to understanding CPG circuitry and ultim-
ately designing novel therapeutics for spinal cord injury.Additional files
Additional file 1: Figure S1. Generation of the Sim1-Puro-pStartTK
targeting vector. 1) Homologous recombination: The backbone was a
Gateway-compatible plasmid, pStartK was amplified by PCR and Sim1
homology arms were incorporated into pStartK from RP23-223 M2 BAC
using red recombinase competent bacteria. 2) Homologous recombination:
Similar to step 1, a chloramphenicol resistance gene flanked by AscI cut sites
from pkD3 was inserted into the open reading frame of the Sim1 gene by
red recombinase competent bacteria. 3) Digest and ligate: The chloram-
phenicol resistance gene was then replaced via restriction enzyme digestion
and ligation by a dual resistance cassette consisting of, from 5’ to 3’: Asc1
cut site, PAC gene, floxed phosphoglycerate kinase I promoter driving
neomycin phosphotransferase (PGK-neo) cassette, and AscI site. 4)
Gateway recombination: A negative selection thymidine kinase gene
was incorporated into the finished Sim1-Puro-pStartTK vector using
pWS-TK3 plasmid and Gateway LR clonase II kit. AMP, Ampicillin resistance
gene; AscI, Restriction enzyme site; attB1 & attB2, Gateway recombination
results; CAT, Chloramphenicol resistance; HA, Homology arm; JPCR, Junction
PCR; KAN, Kanamycin resistance; ori, Origin of replication; PAC, Puromycin
resistance gene; PGK, Phosphoglycerate kinase promoter sequence; Neo,
Neomycin resistance gene; Sim1 ATG, Translation start in Sim1 Exon1; TK,
Thymidine kinase. (TIF 364 kb)
Additional file 2: Figure S2. Identification of non-Sim+ populations post-
selection. (A) Quantification of selected and unselected Sim1-Puro cultures
at 1p +0 stained with Uncx, Nkx2.2, Ki-67, Isl1, and Hb9 at end of selection. *
Denotes P <0.05 compared to unselected group. (B) Quantification of
selected cultures at 1p +0 stained with A2B5 and nestin at end of selection.
(C) Quantification of selected cultures at 1p +7 stained with β-III tubulin,
Ki-67, and O4. (TIF 148 kb)
Additional file 3: Figure S3. Physiological parameters associated with
spiking phenotypes. (A) Rheobase (current required to reach threshold)
plotted versus input resistance for cells from days 2–5 (squares) or days
6–13 (circles) that fired single (open), adapting (grey), or multiple (black)
action potentials during an 800 msec current pulse. Input resistance
decreased with time after selection, but did not correlate with spiking
phenotype. Cells from days 6–13 firing single action potentials had a
significantly higher rheobase (P <0.01, one-way ANOVA on ranks). (B)
Steady-state outward current density (I K density) versus peak inward
current density (I Na density) at 0 mV. Single-spiking cells had the lowest
mean inward current density and the second highest outward current
density but the differences were not significant. (C) Current density ratio
(I Na/I K) versus threshold. Repetitive firing cells from days 6–13 had a
significantly lower threshold (P <0.002, one-way ANOVA). Single-spiking
cells had the lowest mean current density ratio, although the differences
were not significant. (JPG 447 kb)Abbreviations
AMPA: α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CPG: Central
pattern generator; DIG: Digoxigenin; EBs: Embryoid bodies;
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FACS: Fluorescence-activated cell sorting; GABA: γ-Aminobutyric acid;
IN: Interneuron; MN: Motoneuron; NMDA: N-methyl-D-aspartate;
PAC: Puromycin N-acetyl-transferase (puromycin resistance enzyme);
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